Inventor
FOTIN-MLECZEK MARIOLA
DE26 patents
⚠️ This page may combine multiple inventors who share the name “FOTIN-MLECZEK MARIOLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUREVAC AG
17 patentsUS11078247B2Aug 3, 2021
RNA encoding a therapeutic protein
CUREVAC AG57 citations98
US10434158B2Oct 8, 2019
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG31 citations98
US10117920B2Nov 6, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US9974845B2May 22, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US10918740B2Feb 16, 2021
RNA containing composition for treatment of tumor diseases
CUREVAC AG38 citations97
US10293058B2May 21, 2019
RNA containing composition for treatment of tumor diseases
CUREVAC AG50 citations97
US11458195B2Oct 4, 2022
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG12 citations94
US11110166B2Sep 7, 2021
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
CUREVAC AG32 citations94
US10568958B2Feb 25, 2020
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
CUREVAC AG30 citations94
US10111967B2Oct 30, 2018
Complexes of RNA and cationic peptides for transfection and for immunostimulation
CUREVAC AG30 citations94
US10869935B2Dec 22, 2020
RNA containing composition for treatment of tumor diseases
CUREVAC AG29 citations93
US10369216B2Aug 6, 2019
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
CUREVAC AG29 citations93
US11110157B2Sep 7, 2021
Combination of vaccination and OX40 agonists
CUREVAC AG28 citations92
US10307472B2Jun 4, 2019
Combination of vaccination and OX40 agonists
CUREVAC AG31 citations92
US10988754B2Apr 27, 2021
Nucleic acid molecules
CUREVAC AG51 citations91
US11458193B2Oct 4, 2022
Combination of vaccination and inhibition of MHC class I restricted antigen presentation
CUREVAC AG11 citations83
US12178863B2Dec 31, 2024
Combination of vaccination and OX40 agonists
CUREVAC AG0 citations61
CureVac SE
5 patentsUS11596699B2Mar 7, 2023
RNA encoding an antibody
CureVac SE11 citations86
US11559570B2Jan 24, 2023
Prime-boost regimens involving administration of at least one mRNA construct
CureVac SE8 citations86
US11690910B2Jul 4, 2023
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
CureVac SE6 citations74
US12447209B2Oct 21, 2025
Combination of vaccination and inhibition of the PD-1 pathway
CureVac SE0 citations62
US12227549B2Feb 18, 2025
RNA encoding a therapeutic protein
CureVac SE0 citations62